Medicure Inc. (TSXV:MPH)

Medicure Statistics

Total Valuation

Medicure has a market cap or net worth of CAD 10.96 million. The enterprise value is 8.01 million.

Market Cap	10.96M
Enterprise Value	8.01M

Important Dates

The next estimated earnings date is Tuesday, May 19, 2026.

Earnings Date	May 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Medicure has 10.44 million shares outstanding.

Current Share Class	10.44M
Shares Outstanding	10.44M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	26.27%
Owned by Institutions (%)	0.62%
Float	5.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.38
PB Ratio	0.85
P/TBV Ratio	12.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.13
EV / Sales	0.28
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.07.

Current Ratio	1.02
Quick Ratio	0.75
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-80.09

Financial Efficiency

Return on equity (ROE) is -42.13% and return on invested capital (ROIC) is -57.03%.

Return on Equity (ROE)	-42.13%
Return on Assets (ROA)	-15.76%
Return on Invested Capital (ROIC)	-57.03%
Return on Capital Employed (ROCE)	-51.65%
Weighted Average Cost of Capital (WACC)	9.61%
Revenue Per Employee	759,342
Profits Per Employee	-186,763
Employee Count	38
Asset Turnover	1.06
Inventory Turnover	5.50

Taxes

In the past 12 months, Medicure has paid 208,000 in taxes.

Income Tax	208,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +40.96% in the last 52 weeks. The beta is 0.97, so Medicure's price volatility has been similar to the market average.

Beta (5Y)	0.97
52-Week Price Change	+40.96%
50-Day Moving Average	1.15
200-Day Moving Average	1.06
Relative Strength Index (RSI)	52.20
Average Volume (20 Days)	3,006

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medicure had revenue of CAD 28.86 million and -7.10 million in losses. Loss per share was -0.68.

Revenue	28.86M
Gross Profit	11.75M
Operating Income	-6.89M
Pretax Income	-6.89M
Net Income	-7.10M
EBITDA	-5.06M
EBIT	-6.89M
Loss Per Share	-0.68

Balance Sheet

The company has 3.84 million in cash and 891,000 in debt, with a net cash position of 2.94 million or 0.28 per share.

Cash & Cash Equivalents	3.84M
Total Debt	891,000
Net Cash	2.94M
Net Cash Per Share	0.28
Equity (Book Value)	12.91M
Book Value Per Share	1.24
Working Capital	274,000

Cash Flow

Operating Cash Flow	-560,000
Capital Expenditures	n/a
Depreciation & Amortization	1.83M
Net Borrowing	-415,000
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 40.71%, with operating and profit margins of -23.87% and -24.60%.

Gross Margin	40.71%
Operating Margin	-23.87%
Pretax Margin	-23.87%
Profit Margin	-24.60%
EBITDA Margin	-17.54%
EBIT Margin	-23.87%
FCF Margin	n/a

Dividends & Yields

Medicure does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-64.76%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 2, 2012. It was a reverse split with a ratio of 0.0666666.

Last Split Date	Nov 2, 2012
Split Type	Reverse
Split Ratio	0.0666666

Scores

Medicure has an Altman Z-Score of -3.34 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.34
Piotroski F-Score	2